Cenexi has turned EBITDA-positive however hurdles stay. We analyse what this implies for Gland Pharma’s margins, execution and funding case.
Do you have to guess on Gland Pharma after Cenexi's breakeven?
Leave a comment
Search
Cenexi has turned EBITDA-positive however hurdles stay. We analyse what this implies for Gland Pharma’s margins, execution and funding case.
